GP consultations for menstrual disorders after COVID-19 vaccination - A self-controlled cohort study based on routine healthcare data from the Netherlands.

Autor: Jajou R; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands., Lieber T; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands., van Puijenbroek EP; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands; Department of PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, Netherlands., Mulder E; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands., Overbeek J; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands., Hek K; Nivel (Netherlands Institute for Health Services Research), Utrecht, Netherlands., van Hunsel FPAM; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands; Department of PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, Netherlands., Kant A; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, Netherlands; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands. Electronic address: a.kant@lareb.nl.

Publikováno v: Vaccine [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126130. Date of Electronic Publication: 2024 Aug 23.

How could employing the patient perspective transform pharmacovigilance?

Autor: van den Bemt PMLA; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, Groningen, The Netherlands., van Puijenbroek EP; Science and Engineering, University of Groningen, Groningen, The Netherlands.; Netherlands Pharmacovigilance Centre Lareb, s-Hertogenbosch, The Netherlands., van Hunsel FPAM; Science and Engineering, University of Groningen, Groningen, The Netherlands.; Netherlands Pharmacovigilance Centre Lareb, s-Hertogenbosch, The Netherlands.

Publikováno v: Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Jul; Vol. 23 (7), pp. 793-796. Date of Electronic Publication: 2024 Jul 03.

Validation of a Novel Method to Assess the Clinical Quality of Information in Pregnancy-Related Pharmacovigilance Case Reports: A ConcePTION Project.

Autor: van Rijt-Weetink YRJ; Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, s-Hertogenbosch, The Netherlands.; Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands., Egberts TCG; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands., van Hunsel FPAM; Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, s-Hertogenbosch, The Netherlands.; Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands., Lewis DJ; Global Drug Development, Novartis Pharma GmbH, Wehr, Germany.; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK., Yates LM; University of Kwazulu-Natal, KRISP, Durban, South Africa.; Northern Genetics Service, Newcastle-upon-Tyne, UK., Winterfeld U; Swiss Teratogen Information Service and Clinical Pharmacology Service, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland., van Puijenbroek EP; Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, s-Hertogenbosch, The Netherlands. e.vanpuijenbroek@lareb.nl.; Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands. e.vanpuijenbroek@lareb.nl.

Publikováno v: Drug safety [Drug Saf] 2024 Mar; Vol. 47 (3), pp. 261-270. Date of Electronic Publication: 2024 Jan 06.

The Effect of Sex on the Incidence, Latency, Duration and Perceived Burden of Adverse Events Following Seasonal Influenza Vaccination in the Netherlands.

Autor: Slingerland P; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands., van Hunsel FPAM; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands. f.vanhunsel@lareb.nl., Lieber T; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands., van Balveren L; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands., Duijster JW; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands.

Publikováno v: Drug safety [Drug Saf] 2023 Dec; Vol. 46 (12), pp. 1323-1334. Date of Electronic Publication: 2023 Oct 26.

Observed-over-Expected analysis as additional method for pharmacovigilance signal detection in large-scaled spontaneous adverse event reporting.

Autor: van der Boom MDX; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., van Eekeren R; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., van Hunsel FPAM; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.

Publikováno v: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2023 Jul; Vol. 32 (7), pp. 783-794. Date of Electronic Publication: 2023 Mar 21.